More
    Guided Solutions - Connecting Talent With Innovation/div>

    Funding

    Cardiology robotics platform completes seed round of €4.7M with European Heal Capital

    The company will use the funding to develop remote user interaction for structural heart interventions.

    Memic Innovative Surgery Closes $96M Series D Financing

    Financing led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed. Funding primarily supports the commercialisation of...

    Nucleix Secures $55 Million Funding Led by RA Capital Management and Additional Prominent Life Science Investors to Advance Lung EpiCheck® for Early Detection of...

    Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has secured $55 million from a syndicate of leading...

    LumiraDx to merge with CAHC in $5bn deal

    CA Healthcare Acquisition Corp.— a special purpose acquisition company — announced today that it entered a merger agreement with LumiraDx that will take the...

    UroMems Completes €23 Million Series B Financing

    Further participation from existing investors raised additional €7 million Additional capital to fund initiation of the first clinical trial...

    Carb-X announces up to $13.8m funding for STIs diagnostic

    CARB-X is awarding Novel Microdevices, of Baltimore, up to $3.6 million in non-dilutive funding, and, subject to available funding, up to an additional...

    Liquid biopsy device aiming to revolutionise cancer diagnosis

    Scottish biotech company, BioCaptiva, has developed a “liquid biopsy” technology device that aims to revolutionise the early diagnosis and monitoring of difficult...

    Smart hearing company Olive raises $7M in Series B funding

    The company plans to use the new funds to expand its product line. Hearing health company Olive Union landed...

    Holistick raises $5M to boost preclinical development of PFO closure device

     Holistick Medical SAS reported a $5 million round for development of the first generation of a light-activated...

    Latest articles

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4...

    OncoSec Receives CE Mark Certification for its Commercial Electroporation Device “GenPulse™” for the Treatment of Solid Tumors

    CE mark enables commercialization of GenPulse™ in EU OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company"...

    Endologix acquires PQ Bypass to expand vascular product portfolio

    Deerfield Management owned Endologix has acquired medical technology company PQ Bypass to bolster vascular reach to treat unmet medical needs of both...

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million.
    59.5k Followers
    Follow